Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications

Broadly neutralising antibodies (bNAbs) against human immunodeficiency virus type 1 (HIV-1), such as CAP256-VRC26 are being developed for HIV prevention and treatment. These Abs carry a unique but crucial post-translational modification (PTM), namely O-sulfated tyrosine in the heavy chain complement...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Singh, Advaita Acarya, Pooe, Ofentse, Kwezi, Lusisizwe, Lotter-Stark, Therese, Stoychev, Stoyan H., Alexandra, Kabamba, Gerber, Isak, Bhiman, Jinal N., Vorster, Juan, Pauly, Michael, Zeitlin, Larry, Whaley, Kevin, Mach, Lukas, Steinkellner, Herta, Morris, Lynn, Tsekoa, Tsepo Lebiletsa, Chikwamba, Rachel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7148297/
https://ncbi.nlm.nih.gov/pubmed/32277089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63052-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia